Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Www.vynetherapeutics.com save search
SEC Filing: Form 8-K
Published: 2022-04-07 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 13.11%
H: 9.62%
C: -3.19%
VYNE Investor Relations Presentation
Published: 2022-04-07 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 13.11%
H: 9.62%
C: -3.19%
presentation
VYNE Therapeutics Announces Positive Phase 1b Efficacy Data for FMX114 from Phase 1b/2a Trial for the Treatment of Mild-to-Moderate Atopic Dermatitis
Published: 2022-04-07 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 13.11%
H: 9.62%
C: -3.19%
fmx114 treatment dermatitis trial therapeutics positive phase 2b
VYNE Investor Relations Presentation
Published: 2022-06-17 (Crawled : 10:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 8.54%
H: 0.0%
C: -5.74%
presentation
SEC Filing: Form 8-K
Published: 2022-06-17 (Crawled : 18:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 8.54%
H: 0.0%
C: -5.74%
SEC Filing: Form DEF 14A
Published: 2022-06-17 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 8.54%
H: 0.0%
C: -5.74%
VYNE Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-10 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 8.28%
H: 0.0%
C: -6.26%
therapeutics financial update results
SEC Filing: Form 8-K
Published: 2022-11-10 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 8.28%
H: 0.0%
C: -6.26%
VYNE Therapeutics Announces Positive Preclinical Data for Inhaled Formulation of VYN201 in an In Vivo Model of Idiopathic Pulmonary Fibrosis
Published: 2023-04-19 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 7.03%
H: 50.75%
C: 33.13%
vyn201 positive fibrosis preclinical therapeutics
VYNE Investor Relations Presentation
Published: 2022-03-08 (Crawled : 17:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 5.9%
H: 0.0%
C: 0.0%
presentation
SEC Filing: Form 8-K
Published: 2022-03-08 (Crawled : 00:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 5.9%
H: 0.0%
C: 0.0%
SEC Filing: Form 10-K
Published: 2023-03-14 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 5.39%
H: 2.71%
C: -5.12%
VYNE Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-06 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 4.82%
H: 1.15%
C: -3.42%
global conference therapeutics
Lead BET Inhibitor, VYN201, Demonstrates Improvement in Reducing Fibrotic Tissue Mass and Overall Skin Repair Outcomes in Preclinical Study
Published: 2021-11-04 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 4.17%
H: 0.67%
C: -8.0%
skin preclinical pre-clinical
SEC Filing: Form 8-K
Published: 2021-11-04 (Crawled : 15:15) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 4.17%
H: 0.67%
C: -8.0%
SEC Filing: Form 424B5
Published: 2022-03-15 (Crawled : 00:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 4.0%
H: 4.48%
C: -1.16%
SEC Filing: Form 8-K
Published: 2022-03-15 (Crawled : 00:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 4.0%
H: 4.48%
C: -1.16%
VYNE Investor Relations Presentation
Published: 2022-05-17 (Crawled : 14:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 3.76%
H: 0.0%
C: 0.0%
presentation
KOL Event: Novel InhiBET BET Inhibitor Platform
Published: 2022-05-17 (Crawled : 14:20) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 3.76%
H: 0.0%
C: 0.0%
platform
SEC Filing: Form 8-K
Published: 2022-05-17 (Crawled : 21:00) - vynetherapeutics.com
VYNE | $2.4 1.2K
|
Health Technology
|
| O: 3.76%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
SMSI 4 | $2.53 29.74% 510K
|
Technology Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.